News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NAMS over $20
$NAMS: In at $14........ 3k shares Data presented at #ESCCongress and published in the European Heart Journal show "substantial individual variability in the LDL-c reduction" for patients on inclisiran, highlighting the need for new therapies that can reliably reduce LDL-c levels. https://t.co/7iGv7ESGl4 pic.twitter.com/KI22W5JRs2
Letssssssssss goooooooooooooooooooooooooooo
https://www.newamsterdampharma.com/
$12 stop
GO $NAMS
|
Followers
|
0
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2
|
|
Created
|
01/27/23
|
Type
|
Free
|
| Moderators | |||
